Plus, Oppenheimer’s 'golden opportunity for a breakout', why Freedom Capital believes Venezuela oil enthusiasm is 'unjustified', a big bank going full crypto, and more.
Jan 10, 2026
Oct 3, 2026
•
1 min read
Plus, a vaccine maker weeks from its pivotal test....
Oct 1, 2026
One stock pick from a top-ranked analyst with an implied upside of 100% or more.
Sep 26, 2026
Plus, a precision medicine company betting on human genetics....